Skip to main content
. 2017 May 15;2017(5):CD011673. doi: 10.1002/14651858.CD011673.pub2

Analysis 2.2.

Analysis 2.2

Comparison 2 Interferon‐α (IFN‐α) combined with targeted therapy versus standard targeted therapy in first‐line therapy of metastatic renal cell carcinoma, Outcome 2 Overall survival.